ArticleStroke2017

Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".

Andrew D Barreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.